ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 49 filers reported holding ENTRADA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $887,154 | +4.4% | 56,149 | 0.0% | 0.00% | – |
| Q2 2023 | $850,096 | +22.9% | 56,149 | +17.7% | 0.00% | – |
| Q1 2023 | $691,824 | +19.0% | 47,712 | +15.8% | 0.00% | – |
| Q4 2022 | $581,504 | -9.1% | 41,206 | +0.1% | 0.00% | – |
| Q3 2022 | $639,972 | +20.2% | 41,175 | 0.0% | 0.00% | – |
| Q2 2022 | $532,417 | +35.4% | 41,175 | 0.0% | 0.00% | – |
| Q1 2022 | $393,140 | – | 41,175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 72 Investment Holdings, LLC | 509,023 | $7,706,608 | 60.04% |
| MPM ASSET MANAGEMENT LLC | 4,425,784 | $67,006,370 | 32.86% |
| 5AM Venture Management, LLC | 4,408,379 | $66,742,858 | 16.63% |
| StepStone Group LP | 761,277 | $11,525,734 | 2.13% |
| TCG Crossover Management, LLC | 584,955 | $8,856,219 | 1.45% |
| Redmile Group, LLC | 1,311,572 | $19,857,200 | 0.76% |
| Nan Fung Group Holdings Ltd | 49,082 | $743,101 | 0.48% |
| Baker Brothers Advisors | 4,865,819 | $73,668,500 | 0.43% |
| Corton Capital Inc. | 18,067 | $273,534 | 0.13% |
| MOORE CAPITAL MANAGEMENT, LP | 105,000 | $1,589,700 | 0.03% |